Number of Shares
1.38 Mil
Current Holdings Value*
$15.28 Mil
% of Portfolio
3.12%
Total Estimate Gain
$2.12 Mil
% of Total Estimate Gain
9.56%

SILVERARC CAPITAL MANAGEMENT, LLC's UroGen Pharma Ltd Holding Summary

As of 2025-03-31, SILVERARC CAPITAL MANAGEMENT, LLC held 1.38 Mil shares of UroGen Pharma Ltd(URGN), totaling $15.28 Mil. This investment constitutes 3.12% of their stock portfolio, and SILVERARC CAPITAL MANAGEMENT, LLC now holds 3% of the outstanding UroGen Pharma Ltd(URGN) stock.

The initial trade took place in 2023Q3. And since then SILVERARC CAPITAL MANAGEMENT, LLC has made 5 purchases of URGN, at an average price of $13.90, for a total of 1.60 Mil shares. In addition, there have been 2 sales at an average price of $14.96 for 217,688.00 shares. Based on historical transaction data and URGN's current price of $15.27, SILVERARC CAPITAL MANAGEMENT, LLC's estimated gain on his URGN holdings is $2.12 Mil, reflecting a 9.56% gain to date.

SILVERARC CAPITAL MANAGEMENT, LLC URGN ($15.27) Holding Chart

SILVERARC CAPITAL MANAGEMENT, LLC URGN ($15.27) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1